Cell penetrating peptides: Efficient vectors for delivery of nanoparticles, nanocarriers, therapeutic and diagnostic molecules

Efficient delivery of therapeutic and diagnostic molecules to the cells and tissues is a difficult challenge. The cellular membrane is very effective in its role as a selectively permeable barrier. While it is essential for cell survival and function, also presents a major barrier for intracellular delivery of cargo such as therapeutic and diagnostic agents. In recent years, cell-penetrating peptides (CPPs), that are relatively short cationic and/or amphipathic peptides, received great attention as efficient cellular delivery vectors due to their intrinsic ability to enter cells and mediate uptake of a wide range of macromolecular cargo such as plasmid DNA (pDNA), small interfering RNA (siRNAs), drugs, and nanoparticulate pharmaceutical carriers. This review discusses the various uptake mechanisms of these peptides. Furthermore, we discuss recent advances in the use of CPP for the efficient delivery of nanoparticles, nanocarriers, DNA, siRNA, and anticancer drugs to the cells. In addition, we have been highlighting new results for improving endosomal escape of CPP-cargo molecules. Finally, pH-responsive and activable CPPs for tumor-targeting therapy have been described.

[1]  H. Okada,et al.  Development of cell-penetrating peptide-modified MPEG-PCL diblock copolymeric nanoparticles for systemic gene delivery. , 2010, International journal of pharmaceutics.

[2]  Sabine Boeckle,et al.  Melittin analogs with high lytic activity at endosomal pH enhance transfection with purified targeted PEI polyplexes. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[3]  A. Lawrie,et al.  Peptide‐mediated cell penetration and targeted delivery of gold nanoparticles into lysosomes , 2012, Journal of peptide science : an official publication of the European Peptide Society.

[4]  W. Banks,et al.  Transport across the Blood-Brain Barrier of Pluronic Leptin , 2010, Journal of Pharmacology and Experimental Therapeutics.

[5]  Munia Ganguli,et al.  Structural rearrangements and chemical modifications in known cell penetrating peptide strongly enhance DNA delivery efficiency. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[6]  Ű. Langel,et al.  Overcoming methotrexate resistance in breast cancer tumour cells by the use of a new cell-penetrating peptide. , 2006, Biochemical pharmacology.

[7]  C. Montero-Menei,et al.  The potential of combinations of drug-loaded nanoparticle systems and adult stem cells for glioma therapy. , 2011, Biomaterials.

[8]  M. Rhee,et al.  Mechanism of Uptake of C105Y, a Novel Cell-penetrating Peptide* , 2006, Journal of Biological Chemistry.

[9]  Henrik J Johansson,et al.  Characterization of a Novel Cytotoxic Cell-penetrating Peptide Derived From p14ARF Protein. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[10]  B. Nordén,et al.  Stimulated endocytosis in penetratin uptake: effect of arginine and lysine. , 2008, Biochemical and biophysical research communications.

[11]  Igor L. Medintz,et al.  Self-assembled quantum dot-peptide bioconjugates for selective intracellular delivery. , 2006, Bioconjugate chemistry.

[12]  S. Futaki,et al.  Octaarginine-modified liposomes: enhanced cellular uptake and controlled intracellular trafficking. , 2008, International journal of pharmaceutics.

[13]  H. Okada,et al.  Disulfide crosslinked stearoyl carrier peptides containing arginine and histidine enhance siRNA uptake and gene silencing. , 2010, International journal of pharmaceutics.

[14]  Yongzhuo Huang,et al.  TAT-modified nanosilver for combating multidrug-resistant cancer. , 2012, Biomaterials.

[15]  Vladimir P Torchilin,et al.  Bleomycin in octaarginine-modified fusogenic liposomes results in improved tumor growth inhibition. , 2013, Cancer letters.

[16]  Yue-Wern Huang,et al.  Intracellular delivery of quantum dots mediated by a histidine- and arginine-rich HR9 cell-penetrating peptide through the direct membrane translocation mechanism. , 2011, Biomaterials.

[17]  V. Torchilin,et al.  Surface functionalization of doxorubicin-loaded liposomes with octa-arginine for enhanced anticancer activity. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[18]  M. De Waard,et al.  Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231. , 2009, Cancer letters.

[19]  S. M. Robinson,et al.  Polypeptide point modifications with fatty acid and amphiphilic block copolymers for enhanced brain delivery. , 2005, Bioconjugate chemistry.

[20]  S. Gambhir,et al.  Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics , 2005, Science.

[21]  C. Rousselle,et al.  Enhanced delivery of doxorubicin into the brain via a peptide-vector-mediated strategy: saturation kinetics and specificity. , 2001, The Journal of pharmacology and experimental therapeutics.

[22]  Beatriz Pelaz,et al.  The effect of static magnetic fields and tat peptides on cellular and nuclear uptake of magnetic nanoparticles. , 2010, Biomaterials.

[23]  Mark A. Kay,et al.  Progress and problems with the use of viral vectors for gene therapy , 2003, Nature Reviews Genetics.

[24]  G. Rádis-Baptista,et al.  Insights into the Uptake Mechanism of NrTP, A Cell‐Penetrating Peptide Preferentially Targeting the Nucleolus of Tumour Cells , 2012, Chemical biology & drug design.

[25]  J. Conde,et al.  Effect of PEG biofunctional spacers and TAT peptide on dsRNA loading on gold nanoparticles , 2012, Journal of Nanoparticle Research.

[26]  Tae Gwan Park,et al.  PEGylated and MMP-2 specifically dePEGylated quantum dots: comparative evaluation of cellular uptake. , 2009, Langmuir : the ACS journal of surfaces and colloids.

[27]  Sonia Aroui,et al.  Cytotoxicity, intracellular distribution and uptake of doxorubicin and doxorubicin coupled to cell-penetrating peptides in different cell lines: a comparative study. , 2010, Biochemical and biophysical research communications.

[28]  Miriam Scadeng,et al.  Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival , 2010, Proceedings of the National Academy of Sciences.

[29]  Shawn J. Tan,et al.  Surface coating directed cellular delivery of TAT-functionalized quantum dots. , 2009, Bioconjugate chemistry.

[30]  Azam Bolhassani,et al.  Potential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancer. , 2011, Biochimica et biophysica acta.

[31]  Han-Jung Lee,et al.  Arginine-rich cell-penetrating peptides deliver gene into living human cells. , 2012, Gene.

[32]  Keliang Liu,et al.  Enhanced cell uptake of superparamagnetic iron oxide nanoparticles through direct chemisorption of FITC-Tat-PEG₆₀₀-b-poly(glycerol monoacrylate). , 2012, International journal of pharmaceutics.

[33]  Y. Maitani,et al.  Decaarginine-PEG-liposome enhanced transfection efficiency and function of arginine length and PEG. , 2009, International journal of pharmaceutics.

[34]  O. Lequin,et al.  Comparison of penetratin and other homeodomain-derived cell-penetrating peptides: interaction in a membrane-mimicking environment and cellular uptake efficiency. , 2006, Biochemistry.

[35]  Roger Y Tsien,et al.  Systemic in vivo distribution of activatable cell penetrating peptides is superior to that of cell penetrating peptides. , 2009, Integrative biology : quantitative biosciences from nano to macro.

[36]  Erwin G. Van Meir,et al.  Exciting New Advances in Neuro‐Oncology: The Avenue to a Cure for Malignant Glioma , 2010, CA: a cancer journal for clinicians.

[37]  Rongqin Huang,et al.  A leptin derived 30-amino-acid peptide modified pegylated poly-L-lysine dendrigraft for brain targeted gene delivery. , 2010, Biomaterials.

[38]  Roger Y Tsien,et al.  Tumor imaging by means of proteolytic activation of cell-penetrating peptides. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[39]  J. Scherrmann,et al.  CNS Delivery Via Adsorptive Transcytosis , 2008, The AAPS Journal.

[40]  John Archdeacon,et al.  A non-covalent peptide-based carrier for in vivo delivery of DNA mimics , 2007, Nucleic acids research.

[41]  D. Luo,et al.  Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood-brain barrier. , 2008, Biomaterials.

[42]  Jesus M de la Fuente,et al.  Tat peptide as an efficient molecule to translocate gold nanoparticles into the cell nucleus. , 2005, Bioconjugate chemistry.

[43]  C. Berkland,et al.  Calcium condensation of DNA complexed with cell-penetrating peptides offers efficient, noncytotoxic gene delivery. , 2011, Journal of pharmaceutical sciences.

[44]  Quanyin Hu,et al.  The influence of the penetrating peptide iRGD on the effect of paclitaxel-loaded MT1-AF7p-conjugated nanoparticles on glioma cells. , 2013, Biomaterials.

[45]  Cornelis J. Weijer,et al.  Visualizing Signals Moving in Cells , 2003, Science.

[46]  A. Kastin Handbook of biologically active peptides , 2006 .

[47]  T. Tanabe,et al.  The conjugation of diphtheria toxin T domain to poly(ethylenimine) based vectors for enhanced endosomal escape during gene transfection. , 2009, Biomaterials.

[48]  M. Pooga,et al.  Cell penetration by transportan. , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[49]  E. Jabbari,et al.  Drug release kinetics, cell uptake, and tumor toxicity of hybrid VVVVVVKK peptide-assembled polylactide nanoparticles. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[50]  Qi Shen,et al.  Folic acid and cell-penetrating peptide conjugated PLGA-PEG bifunctional nanoparticles for vincristine sulfate delivery. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[51]  D. Ly,et al.  Multicolor Coding of Cells with Cationic Peptide Coated Quantum Dots , 2004 .

[52]  Fan-Ching Chien,et al.  Targeted nuclear delivery using peptide-coated quantum dots. , 2011, Bioconjugate chemistry.

[53]  M. Morris,et al.  Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells. , 2003, Nucleic acids research.

[54]  Maurice Green,et al.  Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein , 1988, Cell.

[55]  Qiang Zhang,et al.  The efficiency of tumor-specific pH-responsive peptide-modified polymeric micelles containing paclitaxel. , 2012, Biomaterials.

[56]  M. Mano,et al.  Cell-Penetrating Peptides—Mechanisms of Cellular Uptake and Generation of Delivery Systems , 2010, Pharmaceuticals.

[57]  Vladimir P Torchilin,et al.  Enhanced cytotoxicity of TATp-bearing paclitaxel-loaded micelles in vitro and in vivo. , 2009, International journal of pharmaceutics.

[58]  Ülo Langel,et al.  Handbook of cell-penetrating peptides , 2006 .

[59]  Soodabeh Davaran,et al.  Quantum dots: synthesis, bioapplications, and toxicity , 2012, Nanoscale Research Letters.

[60]  É. Kiss,et al.  Enhanced cellular uptake and in vitro antitumor activity of short-chain fatty acid acylated daunorubicin-GnRH-III bioconjugates. , 2012, European journal of medicinal chemistry.

[61]  R. Brasseur,et al.  A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[62]  S. Futaki,et al.  Arginine-rich Peptides , 2001, The Journal of Biological Chemistry.

[63]  Jianping Xie,et al.  The potent antimicrobial properties of cell penetrating peptide-conjugated silver nanoparticles with excellent selectivity for gram-positive bacteria over erythrocytes. , 2013, Nanoscale.

[64]  Daniele Gerion,et al.  Fluorescent CdSe/ZnS nanocrystal-peptide conjugates for long-term, nontoxic imaging and , 2004 .

[65]  C. Nunes,et al.  S4(13)-PV cell-penetrating peptide induces physical and morphological changes in membrane-mimetic lipid systems and cell membranes: implications for cell internalization. , 2012, Biochimica et biophysica acta.

[66]  J. Rich,et al.  Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[67]  T. Fujita,et al.  New short interfering RNA-based therapies for glomerulonephritis , 2011, Nature Reviews Nephrology.

[68]  I. Khalil,et al.  Enhanced gene expression by a novel stearylated INF7 peptide derivative through fusion independent endosomal escape. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[69]  Y. Zhen,et al.  A cell penetrating peptide-integrated and enediyne-energized fusion protein shows potent antitumor activity. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[70]  Donald W. Miller,et al.  Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies. , 2001, The Journal of pharmacology and experimental therapeutics.

[71]  Xinguo Jiang,et al.  Penetratin-functionalized PEG-PLA nanoparticles for brain drug delivery. , 2012, International journal of pharmaceutics.

[72]  Juan B. Blanco-Canosa,et al.  Cellular uptake and fate of PEGylated gold nanoparticles is dependent on both cell-penetration peptides and particle size. , 2011, ACS nano.

[73]  F. Ren,et al.  A novel cell-penetrating peptide TAT-A1 delivers siRNA into tumor cells selectively. , 2013, Biochimie.

[74]  R. Schwendener,et al.  Enhanced heparan sulfate proteoglycan-mediated uptake of cell-penetrating peptide-modified liposomes , 2004, Cellular and Molecular Life Sciences CMLS.

[75]  S. Futaki,et al.  Cellular uptake and subsequent intracellular trafficking of R8-liposomes introduced at low temperature. , 2006, Biochimica et biophysica acta.

[76]  I. Mäger,et al.  PepFect14 peptide vector for efficient gene delivery in cell cultures. , 2013, Molecular pharmaceutics.

[77]  J. Conde,et al.  Design of multifunctional gold nanoparticles for in vitro and in vivo gene silencing. , 2012, ACS nano.

[78]  Jeremy C Simpson,et al.  Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[79]  T. Torgerson,et al.  Inhibition of Nuclear Translocation of Transcription Factor NF-κB by a Synthetic Peptide Containing a Cell Membrane-permeable Motif and Nuclear Localization Sequence (*) , 1995, The Journal of Biological Chemistry.

[80]  Cheol Moon,et al.  In vitro assessment of a novel polyrotaxane-based drug delivery system integrated with a cell-penetrating peptide. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[81]  Lin Zhu,et al.  Matrix metalloprotease 2-responsive multifunctional liposomal nanocarrier for enhanced tumor targeting. , 2012, ACS nano.

[82]  J. Xue,et al.  Gene transfer using self-assembled ternary complexes of cationic magnetic nanoparticles, plasmid DNA and cell-penetrating Tat peptide. , 2010, Biomaterials.

[83]  A. F. Saleh,et al.  Improved Tat-mediated plasmid DNA transfer by fusion to LK15 peptide. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[84]  Jeffrey D. Esko,et al.  Heparan sulphate proteoglycans fine-tune mammalian physiology , 2007, Nature.

[85]  Yue-Wern Huang,et al.  A gene delivery system for human cells mediated by both a cell-penetrating peptide and a piggyBac transposase. , 2011, Biomaterials.

[86]  J. Gariépy,et al.  The Pseudomonas aeruginosa exotoxin A translocation domain facilitates the routing of CPP-protein cargos to the cytosol of eukaryotic cells. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[87]  B. Wiesner,et al.  Cellular uptake of an alpha-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically. , 1998, Biochimica et biophysica acta.

[88]  Rangeetha J Naik,et al.  Different roles of cell surface and exogenous glycosaminoglycans in controlling gene delivery by arginine-rich peptides with varied distribution of arginines. , 2013, Biochimica et biophysica acta.

[89]  S. Futaki,et al.  Reprint of: Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: Programmed endosomal escape and dissociation. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[90]  Kevin G. Rice,et al.  Peptide-guided gene delivery , 2007, The AAPS Journal.

[91]  J. Seelig,et al.  Binding and clustering of glycosaminoglycans: a common property of mono- and multivalent cell-penetrating compounds. , 2008, Biophysical journal.

[92]  Min Liu,et al.  Paramagnetic particles carried by cell-penetrating peptide tracking of bone marrow mesenchymal stem cells, a research in vitro. , 2006, Biochemical and biophysical research communications.

[93]  T. Fujiwara,et al.  Leptin-derived peptide, a targeting ligand for mouse brain-derived endothelial cells via macropinocytosis. , 2010, Biochemical and biophysical research communications.

[94]  W. Pardridge,et al.  Blood-brain barrier delivery. , 2007, Drug discovery today.

[95]  C. Berkland,et al.  Calcium condensed cell penetrating peptide complexes offer highly efficient, low toxicity gene silencing. , 2012, International journal of pharmaceutics.

[96]  Qianjun He,et al.  Overcoming multidrug resistance of cancer cells by direct intranuclear drug delivery using TAT-conjugated mesoporous silica nanoparticles. , 2013, Biomaterials.

[97]  J. Esko,et al.  Heparan sulfate proteoglycans. , 2011, Cold Spring Harbor perspectives in biology.

[98]  Ű. Langel,et al.  Molecular parameters of siRNA--cell penetrating peptide nanocomplexes for efficient cellular delivery. , 2013, ACS nano.

[99]  R. Nitschke,et al.  Quantum dots versus organic dyes as fluorescent labels , 2008, Nature Methods.

[100]  Haiyang Tang,et al.  Applications of mesenchymal stem cells labeled with Tat peptide conjugated quantum dots to cell tracking in mouse body. , 2008, Bioconjugate chemistry.

[101]  Gang Bao,et al.  Tat Peptide Is Capable of Importing Large Nanoparticles Across Nuclear Membrane in Digitonin Permeabilized Cells , 2009, Annals of Biomedical Engineering.

[102]  Tianyue Jiang,et al.  Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery. , 2012, Biomaterials.

[103]  Ting-Yi Wang,et al.  Improving the Endosomal Escape of Cell-Penetrating Peptides and Their Cargos: Strategies and Challenges , 2012, Pharmaceuticals.

[104]  Igor L. Medintz,et al.  Delivering quantum dots into cells: strategies, progress and remaining issues , 2009, Analytical and bioanalytical chemistry.

[105]  K. Lim,et al.  Intracellular organelle-targeted non-viral gene delivery systems. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[106]  Shana O Kelley,et al.  Recent advances in the use of cell-penetrating peptides for medical and biological applications. , 2009, Advanced drug delivery reviews.

[107]  A. Marcus,et al.  Imaging and tracking of tat peptide-conjugated quantum dots in living cells: new insights into nanoparticle uptake, intracellular transport, and vesicle shedding. , 2007, Journal of the American Chemical Society.

[108]  T. Maekawa,et al.  Intracellular trafficking of superparamagnetic iron oxide nanoparticles conjugated with TAT peptide: 3-dimensional electron tomography analysis. , 2012, Biochemical and biophysical research communications.

[109]  P. Wender,et al.  The design of guanidinium-rich transporters and their internalization mechanisms. , 2008, Advanced drug delivery reviews.

[110]  Steven F Dowdy,et al.  Cationic TAT peptide transduction domain enters cells by macropinocytosis. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[111]  Brenda Russell,et al.  Delivery and visualization of proteins conjugated to quantum dots in cardiac myocytes. , 2008, Journal of molecular and cellular cardiology.

[112]  T. Ohtsuki,et al.  Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape. , 2009, Advanced drug delivery reviews.

[113]  L. Ren,et al.  Synergistic effects of cell-penetrating peptide Tat and fusogenic peptide HA2-enhanced cellular internalization and gene transduction of organosilica nanoparticles. , 2012, Nanomedicine : nanotechnology, biology, and medicine.

[114]  Kairong Wang,et al.  Design of acid-activated cell penetrating peptide for delivery of active molecules into cancer cells. , 2011, Bioconjugate chemistry.

[115]  N. Kaji,et al.  Quantum dots labeling using octa-arginine peptides for imaging of adipose tissue-derived stem cells. , 2010, Biomaterials.

[116]  P. Johnston,et al.  Molecular mechanisms of drug resistance , 2005, The Journal of pathology.

[117]  X. Qi,et al.  Distinct transduction modes of arginine-rich cell-penetrating peptides for cargo delivery into tumor cells. , 2011, International journal of pharmaceutics.

[118]  Leroy Cronin,et al.  Quantum Dots Protected with Tiopronin: A New Fluorescence System for Cell‐Biology Studies , 2005, Chembiochem : a European journal of chemical biology.

[119]  M. De Waard,et al.  Doxorubicin coupled to penetratin promotes apoptosis in CHO cells by a mechanism involving c-Jun NH2-terminal kinase. , 2010, Biochemical and biophysical research communications.

[120]  Jicun Ren,et al.  Characterization of quantum dot bioconjugates by capillary electrophoresis with laser-induced fluorescent detection. , 2006, Journal of chromatography. A.

[121]  J. Temsamani,et al.  The use of cell-penetrating peptides for drug delivery. , 2004, Drug discovery today.

[122]  K. Makino,et al.  Induction of autophagic cell death of glioma-initiating cells by cell-penetrating D-isomer peptides consisting of Pas and the p53 C-terminus. , 2012, Biomaterials.

[123]  W. Pardridge,et al.  Drug Transport across the Blood–Brain Barrier , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[124]  F. Milletti,et al.  Cell-penetrating peptides: classes, origin, and current landscape. , 2012, Drug discovery today.

[125]  Quanyin Hu,et al.  F3 peptide-functionalized PEG-PLA nanoparticles co-administrated with tLyp-1 peptide for anti-glioma drug delivery. , 2013, Biomaterials.

[126]  Vladimir P Torchilin,et al.  Multifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicity. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[127]  Felix Kratz,et al.  Cell penetrating peptides fused to a thermally targeted biopolymer drug carrier improve the delivery and antitumor efficacy of an acid-sensitive doxorubicin derivative. , 2012, International journal of pharmaceutics.

[128]  E. Clementi,et al.  Macropinocytosis: regulated coordination of endocytic and exocytic membrane traffic events , 2006, Journal of Cell Science.

[129]  Gert Storm,et al.  Constrained and UV-activatable cell-penetrating peptides for intracellular delivery of liposomes. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[130]  K. Parang,et al.  Design and biological evaluation of cell-penetrating peptide-doxorubicin conjugates as prodrugs. , 2013, Molecular pharmaceutics.

[131]  Steven F Dowdy,et al.  Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis , 2004, Nature Medicine.

[132]  Igor L. Medintz,et al.  Intracellular delivery of quantum dot-protein cargos mediated by cell penetrating peptides. , 2008, Bioconjugate chemistry.

[133]  T. Rana,et al.  Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells. , 2004, Chemistry & biology.

[134]  A. Kastin,et al.  Adsorptive endocytosis mediates the passage of HIV-1 across the blood-brain barrier: evidence for a post-internalization coreceptor. , 1998, Journal of cell science.

[135]  V. Torchilin,et al.  Octa-arginine-modified pegylated liposomal doxorubicin: an effective treatment strategy for non-small cell lung cancer. , 2013, Cancer letters.

[136]  Lin‐Yue Lanry Yung,et al.  Synergistic co-delivery of doxorubicin and paclitaxel using multi-functional micelles for cancer treatment. , 2013, International journal of pharmaceutics.

[137]  S. Futaki,et al.  Accumulation of arginine-rich cell-penetrating peptides in tumors and the potential for anticancer drug delivery in vivo. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[138]  Quanyin Hu,et al.  Glioma therapy using tumor homing and penetrating peptide-functionalized PEG-PLA nanoparticles loaded with paclitaxel. , 2013, Biomaterials.

[139]  D. Burgess,et al.  DNA-based therapeutics and DNA delivery systems: A comprehensive review , 2005, The AAPS Journal.

[140]  A. Kabanov,et al.  Mechanism of pluronic effect on P-glycoprotein efflux system in blood-brain barrier: contributions of energy depletion and membrane fluidization. , 2001, The Journal of pharmacology and experimental therapeutics.

[141]  L. Kőhidai,et al.  Daunomycin-polypeptide conjugates with antitumor activity. , 2010, Biochimica et biophysica acta.

[142]  P. Iversen,et al.  Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[143]  B. Nordén,et al.  Cell surface binding and uptake of arginine- and lysine-rich penetratin peptides in absence and presence of proteoglycans. , 2012, Biochimica et biophysica acta.

[144]  A. Magyar,et al.  New daunomycin–oligoarginine conjugates: Synthesis, characterization, and effect on human leukemia and human hepatoma cells , 2009, Biopolymers.

[145]  M. Giacca,et al.  Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules. , 2005, The Biochemical journal.

[146]  Ü. Langel,et al.  A Novel Cell-penetrating Peptide, M918, for Efficient Delivery of Proteins and Peptide Nucleic Acids. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[147]  B. Lagerholm Peptide-mediated intracellular delivery of quantum dots. , 2007, Methods in molecular biology.

[148]  Astrid Gräslund,et al.  Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides. , 2012, Accounts of chemical research.

[149]  Jun F. Liang,et al.  Constructing bioactive peptides with pH-dependent activities , 2009, Peptides.

[150]  Tuan Vo-Dinh,et al.  TAT peptide-functionalized gold nanostars: enhanced intracellular delivery and efficient NIR photothermal therapy using ultralow irradiance. , 2012, Journal of the American Chemical Society.

[151]  Astrid Gräslund,et al.  Mechanisms of Cellular Uptake of Cell-Penetrating Peptides , 2011, Journal of biophysics.

[152]  Ű. Langel,et al.  Delivery of nucleic acids with a stearylated (RxR)4 peptide using a non-covalent co-incubation strategy. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[153]  X. Qi,et al.  Enhancing cellular uptake of activable cell-penetrating peptide–doxorubicin conjugate by enzymatic cleavage , 2012, International journal of nanomedicine.

[154]  S. Kelley,et al.  Cell-penetrating peptides as delivery vehicles for biology and medicine. , 2008, Organic & biomolecular chemistry.

[155]  Vladimir P Torchilin,et al.  Cell-penetrating peptides: breaking through to the other side. , 2012, Trends in molecular medicine.

[156]  W. Jiskoot,et al.  OVCAR-3 cells internalize TAT-peptide modified liposomes by endocytosis. , 2004, Biochimica et biophysica acta.

[157]  A. Herrmann,et al.  Live‐cell analysis of cell penetration ability and toxicity of oligo‐arginines , 2008, Journal of peptide science : an official publication of the European Peptide Society.

[158]  W. Lee,et al.  Cationic oligopeptide‐mediated delivery of dsRNA for post‐transcriptional gene silencing in plant cells , 2004, FEBS letters.

[159]  F. Beltram,et al.  A novel chimeric cell-penetrating peptide with membrane-disruptive properties for efficient endosomal escape. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[160]  G. Tang,et al.  Gene delivery to tumor cells by cationic polymeric nanovectors coupled to folic acid and the cell-penetrating peptide octaarginine. , 2011, Biomaterials.

[161]  J. Spatz,et al.  Conjugation of peptides to the passivation shell of gold nanoparticles for targeting of cell-surface receptors. , 2010, ACS nano.

[162]  Yue-Wern Huang,et al.  Protein transduction in human cells is enhanced by cell-penetrating peptides fused with an endosomolytic HA2 sequence , 2012, Peptides.

[163]  S. Futaki,et al.  Methodological and cellular aspects that govern the internalization mechanisms of arginine-rich cell-penetrating peptides. , 2008, Advanced drug delivery reviews.

[164]  Z. Bozsó,et al.  Cell-penetrating peptide exploited syndecans. , 2010, Biochimica et biophysica acta.

[165]  Yue-Wern Huang,et al.  Nona-Arginine Facilitates Delivery of Quantum Dots into Cells via Multiple Pathways , 2010, Journal of biomedicine & biotechnology.

[166]  J. M. Kumar,et al.  Targeting human epidermal growth factor receptor 2 by a cell-penetrating peptide-affibody bioconjugate. , 2012, Biomaterials.

[167]  P. N. Wang,et al.  Enhancement of Intracellular Delivery of CdTe Quantum Dots (QDs) to Living Cells by Tat Conjugation , 2007, Journal of Fluorescence.

[168]  B. Davidson,et al.  Transvascular delivery of small interfering RNA to the central nervous system , 2007, Nature.

[169]  P. Lundin,et al.  A Peptide-based Vector for Efficient Gene Transfer In Vitro and In Vivo. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[170]  T. Bártfai,et al.  VE-cadherin-derived cell-penetrating peptide, pVEC, with carrier functions. , 2001, Experimental cell research.

[171]  K. Parang,et al.  Cyclic peptide-capped gold nanoparticles as drug delivery systems. , 2013, Molecular pharmaceutics.

[172]  P. Nielsen,et al.  Calcium ions effectively enhance the effect of antisense peptide nucleic acids conjugated to cationic tat and oligoarginine peptides. , 2005, Chemistry & biology.

[173]  H. Cui,et al.  Self-assembled Tat nanofibers as effective drug carrier and transporter. , 2013, ACS nano.

[174]  A. Kabanov,et al.  New technologies for drug delivery across the blood brain barrier. , 2004, Current pharmaceutical design.

[175]  Jean-Pierre Benoit,et al.  Active targeting of brain tumors using nanocarriers. , 2007, Biomaterials.

[176]  Yue-Wern Huang,et al.  Cellular internalization of quantum dots noncovalently conjugated with arginine-rich cell-penetrating peptides. , 2010, Journal of nanoscience and nanotechnology.

[177]  J. Gariépy,et al.  Cell-surface proteoglycans as molecular portals for cationic peptide and polymer entry into cells. , 2007, Biochemical Society transactions.

[178]  C. Contag,et al.  Overcoming multidrug resistance of small-molecule therapeutics through conjugation with releasable octaarginine transporters , 2008, Proceedings of the National Academy of Sciences.

[179]  Min Gong,et al.  Self-assembled peptide (CADY-1) improved the clinical application of doxorubicin. , 2012, International journal of pharmaceutics.

[180]  G. Mariani,et al.  Multidrug resistance in cancer: its mechanism and its modulation. , 2007, Drug news & perspectives.

[181]  Erik J. Sontheimer,et al.  Assembly and function of RNA silencing complexes , 2005, Nature Reviews Molecular Cell Biology.

[182]  Tae Gwan Park,et al.  Thermally triggered cellular uptake of quantum dots immobilized with poly(N-isopropylacrylamide) and cell penetrating peptide. , 2010, Langmuir : the ACS journal of surfaces and colloids.

[183]  Victoria J Allan,et al.  Light Microscopy Techniques for Live Cell Imaging , 2003, Science.

[184]  Ke-Xin Zhang,et al.  Shape effects of nanoparticles conjugated with cell-penetrating peptides (HIV Tat PTD) on CHO cell uptake. , 2008, Bioconjugate chemistry.

[185]  Young-Suk Choi,et al.  Cell‐penetrating chitosan/doxorubicin/TAT conjugates for efficient cancer therapy , 2011, International journal of cancer.

[186]  M. Morris,et al.  Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics , 2009, British journal of pharmacology.

[187]  W. Banks,et al.  Principles of strategic drug delivery to the brain (SDDB): Development of anorectic and orexigenic analogs of leptin , 2011, Physiology & Behavior.

[188]  Mathias Brust,et al.  Uptake and intracellular fate of surface-modified gold nanoparticles. , 2008, ACS nano.

[189]  Álvaro Somoza,et al.  Synthesis and surface modification of uniform MFe2O4 (M = Fe, Mn, and Co) nanoparticles with tunable sizes and functionalities , 2012, Journal of Nanoparticle Research.

[190]  R. Gabathuler,et al.  Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases , 2010, Neurobiology of Disease.

[191]  M. Ishino,et al.  Mutational analysis of HIV-1 Tat minimal domain peptides: Identification of trans-dominant mutants that suppress HIV-LTR-driven gene expression , 1989, Cell.

[192]  Amit Modgil,et al.  Cell penetrating peptide tethered bi-ligand liposomes for delivery to brain in vivo: Biodistribution and transfection. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[193]  M. Morris,et al.  Cell‐penetrating peptides: from molecular mechanisms to therapeutics , 2008, Biology of the cell.

[194]  A. Prochiantz,et al.  Cell Internalization of the Third Helix of the Antennapedia Homeodomain Is Receptor-independent* , 1996, The Journal of Biological Chemistry.

[195]  S. Prakash,et al.  Synthesis of TAT peptide-tagged PEGylated chitosan nanoparticles for siRNA delivery targeting neurodegenerative diseases. , 2013, Biomaterials.

[196]  K. Lee,et al.  Preparation and characterization of nonaarginine-modified chitosan nanoparticles for siRNA delivery. , 2013, Carbohydrate polymers.

[197]  Glenn Walter,et al.  Rapid and effective labeling of brain tissue using TAT-conjugated CdS:Mn/ZnS quantum dots. , 2005, Chemical communications.

[198]  C. Berkland,et al.  Calcium condensed LABL-TAT complexes effectively target gene delivery to ICAM-1 expressing cells. , 2011, Molecular pharmaceutics.

[199]  I. Neundorf,et al.  Knockdown of a G protein-coupled receptor through efficient peptide-mediated siRNA delivery. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[200]  Shiroh Futaki,et al.  High Density of Octaarginine Stimulates Macropinocytosis Leading to Efficient Intracellular Trafficking for Gene Expression* , 2006, Journal of Biological Chemistry.

[201]  Yu Chen,et al.  Nuclear-targeted drug delivery of TAT peptide-conjugated monodisperse mesoporous silica nanoparticles. , 2012, Journal of the American Chemical Society.